Phase I and Pharmacokinetic Study of E7820 After Oral Administration to Patients With Malignancy.
Phase of Trial: Phase I
Latest Information Update: 30 Dec 2014
At a glance
- Drugs E 7820 (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 11 Sep 2009 New trial record